Dr. Analisa Arosemena, MD

Dr. Arosemena practices at South Florida Surgery Center in Miami, Florida.

Dr. Arosemena's NPI, 1346346491, was assigned on September 16, 2006. Dr. Arosemena graduated from Universidad Autonoma de Guadalajara in 1998. Dr. Arosemena holds Florida license ME96008.

Dr. Arosemena's primary practice is South Florida Surgery Center, at 6110 Sw 70th St, Miami, FL 33143. The practice phone is (305) 662-3100.

Dr. Arosemena's primary practice is South Florida Surgery Center in Miami, Florida. Dmand AI also links Dr. Arosemena to 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arosemena practices, 4 sites in all. Vendor and product names are available with a free account.

Glaucoma specialist is Dr. Arosemena's primary specialty in the NPI Registry, under taxonomy code 207WX0009X. Dr. Arosemena is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Arosemena's licenses on file in 2 states: Florida and Louisiana.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, glaucoma, glaucoma surgery, secondary membranaous cataract surgery and vision problems among the conditions Dr. Arosemena treats.

CMS data shows 338 Medicare services from Dr. Arosemena across 12 procedure codes in 2024, for 97 Medicare patients. Medicare paid $25,453 for them. Every service was in an office.

CMS counts 97 Medicare patients who saw Dr. Arosemena in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Arosemena's median patient age at 72, with 58% women.

In 2024, Dr. Arosemena wrote 5,630 Medicare Part D claims for 1,280 patients. 48% of them were for generic drugs. CMS names the drug for 5,503 of them, across 32 drugs with 11 or more claims each, at $732,551 in total drug cost. In 2023, CMS named 23,529 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Arosemena for performance year 2024, reported as part of a group. Dr. Arosemena accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 94 procedures of cataract surgery by Dr. Arosemena, more than 73% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Arosemena in 2016. Dr. Arosemena has published most often in J Cataract Refract Surg. Dr. Arosemena's most frequent co-authors are Ramesh Somayajula Ayyala, MD, Erin A. Boese, MD and David A. Crandall, MD.

CMS Open Payments shows 1,021 general payments to Dr. Arosemena from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Abbvie Inc. paid the most, $109,400.

Dmand AI lists 1 award for Dr. Arosemena, most recently CMS Stage 1 EHR in 2013.

Dr. Arosemena graduated from Universidad Autonoma de Guadalajara in 1998.

Dr. Arosemena is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.